SEC 13F Intelligence

Matarin Capital Management, LLC / ARWR

Matarin Capital Management, LLC’s Arrowhead Pharmaceuticals In Position

Does Matarin Capital Management, LLC own Arrowhead Pharmaceuticals In (ARWR)? Not currently — the last reported position was 193.2K shares worth $12M in Q4 2019; the fund’s latest 13F (Q4 2020) no longer reports it.

Position Value
$12M
Q4 2019
Shares
193.2K
% of Portfolio
+1.17%
Quarters Held
4
position exited

Position History ARWR

Reported value by quarter
Q1 ’19: $4MQ1 ’19Q2 ’19: $10MQ2 ’19Q3 ’19: $10MQ3 ’19Q4 ’19: $12MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2019193.2K$12M+1.17%
Q3 2019354.6K$10M+0.76%
Q2 2019385.2K$10M+0.73%
Q1 2019216.4K$4M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Matarin Capital Management, LLC’s full portfolio or all institutional holders of ARWR.